Further, the Kaplan–Meier survival plot for CCNG2 in prostate cancer suggests that low CCNG2 expression is linked with diminished survival rates in PCa over time (Fig. 4H) suggesting that CCNG2 is part of a tumor suppressive program induced by SAL. The gene discussed is CCNG2; the disease is posterior cortical atrophy.